期刊文献+

Ethambutol-induced optic neuropathy with rare bilateral asymmetry onset:A case report 被引量:1

下载PDF
导出
摘要 BACKGROUND Ethambutol-induced optic neuropathy(EON)most commonly manifests as bilateral symmetrical loss of vision and often cause serious and irreversible visual impairment because of the lack of early detection and effective treatment.We followed a case of EON with rare binocular asymmetric clinical manifestations and observed the changes of visual function and retinal structure after drug withdrawal,so as to further understand the clinical characteristics of this disease.CASE SUMMARY A 54-year-old man complained of gradual visual decline in the left eye.The patient presented with best-corrected visual acuity of 20/20 in the right eye and 20/50 in the left eye.Color vision examination revealed difficulty in reading green color plates in the left eye.The visual field manifested as concentric contraction in the left eye.After nearly a month of drug withdrawal,the right eye had a similar decline in visual function.At the last visit,19 mo after drug withdrawal,the visual function significantly recovered in both eyes.During follow-up optical coherence tomography(OCT)examination,both eyes manifested the thickness of the retinal nerve fiber layer from mild thickening to thinning and finally temporal atrophy,and the ganglion cell-inner plexiform layer showed significant thinning.The difference was that a reversible structural disorder in the outer retina of the nasal macula was detected in the left eye by macular high-definition OCT.CONCLUSION Nephropathy and high blood pressure,which damage the retinal microcirculation,may cause damage to the outer layer of the retina.Ethambutol may influence photoreceptor as well as retinal ganglion cells.
出处 《World Journal of Clinical Cases》 SCIE 2022年第2期663-670,共8页 世界临床病例杂志
基金 Supported by the Hangzhou Science and Technology Development Project,No.20170533B70.
  • 相关文献

参考文献1

二级参考文献31

  • 1Boulanger-Scemama E, Touitou V, Le Hoang P (2013) Bitemporal hernianopia as presenting sign of severe etharnbutol toxicity. J Fr Ophtalrnol 36:e163-167.
  • 2Chai SJ, Foroozan R (2007) Decreased retinal nerve fibre layer thickness detected by optical coherence tomography in patients with ethambu- tol-induced optic neuropathy. Br J Ophthalmo191: 895-897.
  • 3ChatziraUi IP, Papazisis L, Keryttopoulos P, Papadopoulou D, Sergen- tanis TN (2010) Disentangling renal function in the context of irre- versible ethambutol optic neuropathy. Int Ophthalmo130:743-744.
  • 4Costello F, Coupland S, Hodge W, Lorello GR, Koroluk J, Pan YI, Freed- man MS, Zackon DH, Kardon RH (2006) Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 59:963-969.
  • 5Fonkem E, Skordilis MA, Binkley EM, Raymer DS, Epstein A, Arnold WD, Kissel JT, Lawson VH (2013) Ethambutol toxicity exacerbating the phenotype of GMT2A2. Muscle Nerve 48:140-144.
  • 6Fraunfelder FW, Sadun AA, Wood T (2006) Update on ethambutol op- tic nenropathy. Expert Opin Drug Saf 5:615-618.
  • 7Garcia-Martin E, Polo V, Larrosa JM, Marques ML, Herrero R, Martin J, Ara JR, Fernandez J, Pablo LE (2014) Retinal layer segmentation in patients with multiple sclerosis using spectral domain optical coher- ence tomography. Ophthalmology 12!:573-579.
  • 8Garway-Heath DF, Poinoosawmy D, Fitzke FW, Hitchings RA (2000) Mapping the visual field to the optic disc in normal tension glauco- ma eyes. Ophthalmology 107:1809-1815.
  • 9Geyer HL, Herskovitz S, Slamovits TL, Schaumburg HH (2014) Opto- chiasmatic and peripheral neuropathy due to ethambutol overtreat- ment. J Neuroophthalmo134:257-258.
  • 10Kanarnori A, Escano MF, Eno A, Nakamura M, Maeda H, Seya R, Ishibashi K, Negi A (2003) Evaluation of the effect of aging on retinal nerve fiber layer thickness measured by optical coherence tomogra- phy. Ophthalmologica 217:273-278.

共引文献4

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部